Julia Cartwright explores why a 10-15% body weight loss through semaglutide transforms metabolic health. Learn how the STEP-1 trial revealed profound improvements in blood pressure, cholesterol, insulin resistance, liver function, and inflammation—changes that prevent heart attacks, strokes, and chronic disease, making seemingly modest weight loss clinically life-saving.
Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV
This content was created in partnership and with the help of Artificial Intelligence AI
続きを読む
一部表示